Michael A. Metzger
2018
In 2018, Michael A. Metzger earned a total compensation of $1.5M as Chief Operating Officer at Syndax Pharmaceuticals, a 24% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $221,540 |
---|---|
Option Awards | $790,532 |
Salary | $506,375 |
Other | $3,000 |
Total | $1,521,447 |
Metzger received $790.5K in option awards, accounting for 52% of the total pay in 2018.
Metzger also received $221.5K in non-equity incentive plan, $506.4K in salary and $3K in other compensation.
Rankings
In 2018, Michael A. Metzger's compensation ranked 7,094th out of 14,244 executives tracked by ExecPay. In other words, Metzger earned more than 50.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,094 | 50th |
Manufacturing | 2,726 | 53rd |
Chemicals And Allied Products | 1,027 | 52nd |
Drugs | 866 | 52nd |
Pharmaceutical Preparations | 676 | 51st |
Metzger's colleagues
We found two more compensation records of executives who worked with Michael A. Metzger at Syndax Pharmaceuticals in 2018.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019